ESC Premium Access

Trends in incidence and mortality from non-rheumatic degenerative mitral valve disease across europe, over the past three decades.

Congress Session

About the speaker

Doctor Becker Al-khayatt

East Surrey Hospital, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

4 more presentations in this session

Circulating transforming growth factor-beta1 and progression of the mitral valve prolapse: fifteen-year follow-up

Speaker: Professor E. Malev (Saint Petersburg, RU)

Thumbnail

The MIDA Quantitative mortality risk score: prognostic model in floppy mitral valves

Speaker: Doctor B. Essayagh (Rochester, US)

Thumbnail

Myocardial efficiency in severe asymptomatic primary mitral regurgitation: relation to quantitative measures of regurgitation

Speaker: Professor J. Sorensen (Uppsala, SE)

Thumbnail

Clinical and haemodynamic effects of percutaneous edge-to-edge mitral valve repair in atrial versus ventricular functional mitral regurgitation

Speaker: Professor M. Claeys (Antwerp, BE)

Thumbnail

Access the full session

A deep dive into mitral regurgitation

Speakers: Doctor B. Al-khayatt, Professor E. Malev, Doctor B. Essayagh, Professor J. Sorensen, Professor M. Claeys
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Is it really justifiable for the EMS to bypass the nearest hospital for cardiac arrest?

30 August 2021

ESC Premium Access

Nonobstructive coronary artery disease: why bother? - Chat Moderator.

30 August 2021

Open Access

Live Q&A.

29 August 2021

This platform is supported by

logo Novo Nordisk